Cancer surgery in Canada during the COVID-19 pandemic: qualitative analysis of cancer surgeons' perspectives
Br J Surg
.
2022 Sep 9;109(10):1019-1020.
doi: 10.1093/bjs/znac227.
Authors
Julie Lee
1
,
Harminder Singh
2
3
4
,
Kathleen Decker
2
4
5
,
Ramzi Helewa
6
,
Marylise Boutros
7
,
Jason Park
8
Affiliations
1
Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
2
Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
3
Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
4
CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
5
Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
6
Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.
7
Department of Surgery, McGill University, Montreal, Quebec, Canada.
8
Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
PMID:
35759410
PMCID:
PMC9384423
DOI:
10.1093/bjs/znac227
No abstract available
MeSH terms
COVID-19* / epidemiology
Humans
Neoplasms* / epidemiology
Neoplasms* / surgery
Pandemics
SARS-CoV-2
Surgeons*